Position in BIIB
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,594,738
New position
Shares Held
7,381
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#374
of 1,031 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HAGER INVESTMENT MANAGEMENT SERVICES, LLC holds $12,489,605 across 12 Drug Manufacturers - General names. BIIB ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,593 | $5,508,982 | |
| 2 | MRK |
Merck & Co., Inc.
|
14,795 | $1,901,157 | |
| 3 | BIIB |
Biogen Inc.
This page
|
7,381 | $1,594,738 | |
| 4 | ABBV |
AbbVie Inc.
|
5,407 | $1,360,617 | |
| 5 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 6 | JNJ |
Johnson & Johnson
|
1,877 | $476,701 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,431 | $307,132 | |
| 8 | NVO |
Novo Nordisk A S
|
602 | $28,859 |
All Filings in BIIB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,594,738 | 7,381 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||